Sollievo Pharmaceuticals (Equity)
Funding Details
- Awarder
- StartEngine
- Date Award
- June 13, 2024
- Vertical
- Pharmaceuticals
- Funding URL
- View Funding Page
- Premoney Valuation
- $1,000,000
- Valuation
- $20,000,000
- Funding Amount:
- $40,000,000
Company Info
- Founding Year
- Not provided in the memo
- Traction
- None
- Organizations Involved
- None
- Founders
- Robert Schultz, Peter Schineller, Steve King
- Company Description
- Sollievo Pharmaceuticals is seeking to improve safety for healthcare staff with our first product, Proviza. Proviza is a fast-acting sedative developed to address the rising incidence of injuries and abuse to healthcare staff when treating agitated and aggressive patients. Sollievo Pharmaceuticals is pre-revenue and in the development and scale-up stages.
- Market
- Healthcare
- Location
- San Juan Capistrano, CA, US
- Coinvestors
- None